Measure | T0: Baseline | T1: posttreatment | T2: 4-months Follow-up | T3: 10-months Follow-up |
---|---|---|---|---|
Interview: | Â | Â | Â | Â |
Composite International Diagnostic Interview (CIDI) | X | Â | Â | Â |
Perceived Need of Care Questionnaire (PNCQ) | X | Â | Â | Â |
Expanded Disability Status Scale (EDSS) | X | Â | Â | Â |
Self-report measurements: | Â | Â | Â | Â |
Demografics & Medical MS data | X | Â | Â | Â |
Medication and treatment information | X | X | X | X |
Beck Depression Inventory (BDI-II) | X | X | X | X |
Beck Anxiety Inventory (BAI) | X | X | X | X |
Hospital Anxiety and Depression Scale (HADS-A) | X | X | X | X |
Fatigue Severity Scale (FSS) | X | X | X | X |
Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) | X | X | X | X |
Multiple Sclerosis Impact Scale (MSIS-29) | X | X | X | X |
EuroQol (EQ-6D) | X | X | X | X |
Social Support Inventory | X | X | X | X |
Social Problem Solving Inventroy-Revised (SPSI-R) | X | X | X | X |
Pearlin Mastery Scale | X | X | X | X |
Client Staisfaction Questionnaire (CSQ-8) | Â | X | Â | X |
Visual Analoge Scale (VAS) to evaluate the intervention | Â | X | Â | Â |